Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11846280 | 1.00 | ALDH1A1 (0.56) | ALDH1A1LMNACYP3A4TDP1ACHE | |
| SCHEMBL11839580 | 1.00 | ALDH1A1 (0.56) | ALDH1A1LMNACYP3A4TDP1ACHE | |
| SCHEMBL11841421 | 0.87 | ALDH1A1 (0.58) | ALDH1A1LMNACYP3A4TDP1 | |
| SCHEMBL11841417 | 0.87 | ALDH1A1 (0.58) | ALDH1A1LMNACYP3A4TDP1 | |
| SCHEMBL15609240 | 0.85 | ALDH1A1 (0.39) | ALDH1A1LMNACYP3A4TDP1ACHE | |
| SCHEMBL15609241 | 0.85 | ALDH1A1 (0.39) | ALDH1A1LMNACYP3A4TDP1ACHE | |
| SCHEMBL11849203 | 0.85 | ALDH1A1 (0.70) | ALDH1A1LMNACYP3A4TDP1 | |
| SCHEMBL11849196 | 0.85 | ALDH1A1 (0.70) | ALDH1A1LMNACYP3A4TDP1 | |
| SCHEMBL11872547 | 0.84 | ALDH1A1 (0.67) | ALDH1A1LMNACYP3A4TDP1 | |
| SCHEMBL11872541 | 0.84 | ALDH1A1 (0.67) | ALDH1A1LMNACYP3A4TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170325457-A1 | FORMULATIONS FOR THE DELIVERY OF ACTIVE AGENTS TO INSECTS, PLANTS, AND PLANT PATHOGENS | Preceres Inc. (US) | 2017-11-16 | — | — | US | disclosed |
| US-20170325457-A1 | FORMULATIONS FOR THE DELIVERY OF ACTIVE AGENTS TO INSECTS, PLANTS, AND PLANT PATHOGENS | Preceres Inc. (US) | 2017-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170325457-A1 | FORMULATIONS FOR THE DELIVERY OF ACTIVE AGENTS TO INSECTS, PLANTS, AND PLANT PATHOGENS | NSF, GET3, SLC47A2 | ALDH1A1 4714/4885LMNA 3934/4885CYP3A4 4388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.